In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
Authors say findings reframe clinical success of lifestyle interventions
FDA Approves Polypill Widaplik for Hypertension
Approval marks first triple-combination pill of telmisartan, amlodipine, and indapamide
Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis
Decrease in survival benefits with age in expanded criteria donor kidney transplant recipients, especially those with CVD
Increasing Proportion of U.S. Adults Unaware They Have Hypertension
No change seen in proportion of adults unaware they had diabetes or high cholesterol levels
Preoperative Blood Pressure Strategies Yield Similar Postoperative Cognitive Results
Neurocognitive outcomes do not differ with hypotension-, hypertension-avoidance strategies for patients undergoing noncardiac surgery
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
Risk for major adverse cardiac and cerebrovascular events lower compared with aspirin monotherapy for patients who undergo PCI and discontinue DAPT
Work Context Linked to Cardiovascular Disease Risk Factors
Self-employment linked to favorable CVD risk profile among minority and nonminority women
Cardiometabolic Risk Factors Account for More Than One-Third of Dementia Risk
Hypertension, ischemic heart disease, and chronic heart failure have the greatest attributable fractions
2021 to 2023 Saw Rise in Cannabis Use by Older Adults
Notable shifts seen among those with higher income and certain clinical conditions